Last reviewed · How we verify
Glucomag (magnesium gluconate)
Glucomag (generic name: magnesium gluconate) is a magnesium gluconate drug. It is currently in unknown development for Constipation, Hypomagnesemia, Incomplete passage of stool.
Glucomag works by replenishing magnesium levels in the body, which helps to regulate muscle and nerve function.
Glucomag, also known as magnesium gluconate, is a small molecule drug in the magnesium gluconate class. It is used to treat conditions such as constipation, hypomagnesemia, incomplete passage of stool, and indigestion. The commercial status of Glucomag is unknown, but it is likely available as a generic medication. Key safety considerations include potential gastrointestinal side effects. Glucomag is not FDA-approved for any indications.
At a glance
| Generic name | magnesium gluconate |
|---|---|
| Drug class | magnesium gluconate |
| Therapeutic area | Gastroenterology |
| Phase | unknown |
Mechanism of action
Think of magnesium like a key that helps your muscles and nerves work properly. When you're low on magnesium, your muscles can get stiff and your nerves can get a little mixed up. Glucomag helps to replace that magnesium, so your body can function normally again.
Approved indications
- Constipation
- Hypomagnesemia
- Incomplete passage of stool
- Indigestion
Common side effects
- Body tinea
- Infection susceptibility increased
- Inhibitory drug interaction
- Glucose tolerance impaired
- Bone density decreased
- Poor quality sleep
- Purpura
- Hyperlipidaemia
- Oral herpes
- Impaired quality of life
- Impaired work ability
- Discoloured vomit
Key clinical trials
- Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis (PHASE3)
- Evaluation of the Impact of a Nutritional Formulation on Cognitive Performance Following Stress Exposure. (NA)
- Early Intravenous Magnesium Sulfate and Its Impact on Cerebral Vasospasm in Traumatic Subarachnoid Hemorrhage (EARLY_PHASE1)
- Evaluation of Collagen-based Medical Device Treatment Combined With Physiotherapy in Subjects With Achilles Tendinopathy. (NA)
- The Effect of Different Types of Mouthwash on Extraction Sockets' Healing (PHASE4)
- Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy (PHASE3)
- Evaluation of the Efficacy of a Food Supplement in Reducing Hair Loss in Male Subjects (NA)
- Comparison of Mg Vs. K Supplementation on Insomnia in Diabetics (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Glucomag CI brief — competitive landscape report
- Glucomag updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Glucomag
What is Glucomag?
How does Glucomag work?
What is Glucomag used for?
What is the generic name of Glucomag?
What drug class is Glucomag in?
What development phase is Glucomag in?
What are the side effects of Glucomag?
Related
- Drug class: All magnesium gluconate drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Gastroenterology
- Indication: Drugs for Constipation
- Indication: Drugs for Hypomagnesemia
- Indication: Drugs for Incomplete passage of stool
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing